Update:
Amfora made steady progress during the quarter. We completed harvest of nearly 10,000 T2 and T3 lines from our gene editing program to increase the protein content of soy. We analyzed the DNA sequence of a subset of lines and found multiple lines with edits consistent with our CRISPR experimental design. Previous analysis of T2 seeds showed increased protein content related to deletions in the NF-YC4 promoter. We expect to confirm those results and undertake more detailed analyses of the Summer 2020 Iowa harvest over the upcoming quarter.
Update:
Amfora made progress on the commercial front during the quarter. We are in process of making meal and texturized protein from 1,000 lbs of our AMFUHP101, a variety that yields soy meal with 64-65% protein. This meal will be used for functional studies in plant-based meat applications and aquaculture feed applications.
Molecular and composition analysis of our most advanced gene edited lines suggest some watch outs, and we may have to fall back to our next generation of gene edited lines. We have increased resources on next generation editing to minimize the impact on our development timeline should we need to fall back to this next generation of edits.
Update:
Amfora continued to make both R&D and commercial progress during Q2 of 2021. We have supplied samples of soy meal and TVP to several potential plant-based meat customers, we initiated a new gene-editing project with Plastomics as a contract service provider, and we planted North America wide area trials to evaluate both our high and ultra-high protein germplasm as well as public and private germplasm available to license as base germplasm for our gene editing and soy breeding programs.